
Following the launch of the new website, we are working on restructuring the Community site.
Until this work is finished, some content you find here may still be relevant but some may be outdated.
To find still published content on this site, use the Search box above.
Geographical Group Reporting Submission
Cochrane Madrid (IRYCIS/Universidad Francisco de Vitoria)
Jesús Lopez-Alcalde
Published Prognosis Factor Non-Cochrane Systematic Review: CD4/CD8 ratio and CD8+ T-cell count as prognostic markers for non-AIDS mortality in people living with HIV. A systematic review and meta-analysis
Yes
Department of Infectious Diseases, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain
Jesus Lopez-Alcalde
cochrane.madrid@ufv.es
cochrane.madrid@ufv.es
Evidence production
Our results support the use of the CD4/CD8 ratio as a prognostic marker in clinical practice, especially in patients with values below 0.5, but consensus criteria on ratio timing measurement, cut-off values, and time to event are needed in future studies to get more robust conclusions.